Insulin Resistance, Obesity, Hypofibrinolysis, Hyperandrogenism, and Coronary Heart Disease Risk Factors in 25 Pre-Perimenarchal Girls Age <14 Years, 13 with Precocious Puberty, 23 with a First-degree Relative with Polycystic Ovary Syndrome

作者: C.J. Glueck , J.A. Morrison , P. Wang

DOI: 10.1515/JPEM.2008.21.10.973

关键词:

摘要: Background: Pre-peri-menarchal diagnosis of polycystic ovary syndrome (PCOS) is important, because intervention with metformin-diet may prevent progression to full blown PCOS. Hypothesis: In 25 girls age ≤14 years probable familial PCOS, 10 pre-, 15 post-menarchal, 13 precocious puberty, 23 a first-degree relative we hypothesized that reversible coronary heart disease (CHD) risk factors, insulin resistance, clinical and biochemical hyperandrogenism, hypofibrinolysis were already established. Methods: Fasting measures: insulin, glucose, total, LDL- (LDL-C), HDL-cholesterol (HDL-C), triglycerides (TG), systolic diastolic blood pressure (SBP, DBP), plasminogen activator inhibitor activity (PAI-Fx), total (T) free testosterone (FT), androstenedione, DHEAS. Results: Clinical and/or hyperandrogenism was present in all girls, elevations T or FT, androstenedione seven ten pre-menarchal post-menarche. PAI-Fx high 28% the vs 6.5% age-gender-race matched controls (p = 0.013). Categorized by race-age-specific distributions 870 schoolgirls, PCOS more likely have top decile body mass index (BMI), HOMA-insulin resistance (HOMA-IR), SBP, DBP, TG, bottom HDL-C. By analysis variance, adjusting for race, BMI, had higher FT waist circumference than controls, but did not differ HDL-C, TG >0.05). Conclusions: acquisition centripetal obesity amplifies CHD factors hyperandrogenemic puberty. When schoolgirls become as obese they acquire same only lower less obesity.

参考文章(19)
Carla Pelusi, Renato Pasquali, Polycystic ovary syndrome in adolescents: pathophysiology and treatment implications. Treatments in Endocrinology. ,vol. 2, pp. 215- 230 ,(2003) , 10.2165/00024677-200302040-00001
Richard S Legro, Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. Journal of Pediatric Endocrinology and Metabolism. ,vol. 15, pp. 1367- 1378 ,(2002)
R. Homburg, Polycystic Ovary Syndrome in Adolescence Endocrine development. ,vol. 8, pp. 137- 149 ,(2005) , 10.1159/000084099
C.J Glueck, Ping Wang, Robert Fontaine, Trent Tracy, Luann Sieve-Smith, Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS). Journal of Adolescent Health. ,vol. 29, pp. 160- 169 ,(2001) , 10.1016/S1054-139X(01)00202-6
George Mastorakos, Irene Lambrinoudaki, George Creatsas, Polycystic ovary syndrome in adolescents: current and future treatment options. Pediatric Drugs. ,vol. 8, pp. 311- 318 ,(2006) , 10.2165/00148581-200608050-00004
Maria Trent, S. Bryn Austin, Michael Rich, Catherine M. Gordon, Overweight status of adolescent girls with polycystic ovary syndrome: body mass index as mediator of quality of life. Ambulatory Pediatrics. ,vol. 5, pp. 107- 111 ,(2005) , 10.1367/A04-130R.1
I. Guttmann-Bauman, Approach to Adolescent Polycystic Ovary Syndrome (PCOS) in the Pediatric Endocrine Community in the USA Journal of Pediatric Endocrinology and Metabolism. ,vol. 18, pp. 499- 506 ,(2005) , 10.1515/JPEM.2005.18.5.499
Samantha M. Pfeifer, Polycystic ovary syndrome in adolescent girls Seminars in Pediatric Surgery. ,vol. 14, pp. 111- 117 ,(2005) , 10.1053/J.SEMPEDSURG.2005.01.007
Areej Hassan, Catherine M Gordon, Polycystic ovary syndrome update in adolescence Current Opinion in Pediatrics. ,vol. 19, pp. 389- 397 ,(2007) , 10.1097/MOP.0B013E328236743F
L. Ibáñez, A. Jaramillo, G. Enríquez, E. Miró, A. López-Bermejo, D. Dunger, F. de Zegher, Polycystic ovaries after precocious pubarche: relation to prenatal growth Human Reproduction. ,vol. 22, pp. 395- 400 ,(2007) , 10.1093/HUMREP/DEL395